New blood test benchmarks for pregnant women could prevent dangerous clots
NCT ID NCT06133621
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 100 pregnant women to determine normal ranges for a blood test called dRVVT, which checks for clotting problems. The goal is to better identify antiphospholipid syndrome, a condition that raises the risk of blood clots and pregnancy complications. By establishing reference values for healthy pregnancies, doctors can more accurately diagnose and manage at-risk women.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better diagnose antiphospholipid syndrome in pregnant women, leading to improved monitoring and treatment to prevent complications like blood clots or pregnancy loss.
- What could go wrong
- This is a small, completed observational study that only establishes reference values. It does not test a treatment, so it cannot directly improve outcomes without further research.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NORMAL PREGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr Céline BAZIN
Lyon, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.